Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
J Nutr ; 147(6): 1079-1085, 2017 06.
Article in English | MEDLINE | ID: mdl-28424260

ABSTRACT

Background: Estimated physiologic requirements (PRs) for zinc increase in late pregnancy and early lactation, but the effect on dietary zinc requirements is uncertain.Objective: The aim of this study was to determine changes in daily fractional absorbed zinc and total absorbed zinc (TAZ) from ad libitum diets of differing phytate contents in relation to physiologic zinc requirements during pregnancy and lactation.Methods: This was a prospective observational study of zinc absorption at 8 (phase 1) and 34 (phase 2) wk of gestation and 2 (phase 3) and 6 (phase 4) mo of lactation. Participants were indigenous Guatemalan women of childbearing age whose major food staple was maize and who had been randomly assigned in a larger study to either of 2 ad libitum feeding groups: low-phytate maize (LP; 1.6 mg/g; n = 14) or control maize (C; 7.1 mg/g; n = 8). Total dietary zinc (milligrams per day, TDZ) and phytate (milligrams per day) were determined from duplicate diets and fractional absorption (FAZ) by dual isotope ratio technique (TAZ = TDZ × FAZ). All variables were examined longitudinally and by group and compared with PRs. TAZ values at later phases were compared with phase 1. Measured TAZ was compared with predicted TAZ for nonpregnant, nonlactating (NPNL) women.Results: TAZ was greater in the LP group than in the C group at all phases. All variables increased from phase 1 to phases 2 and 3 and declined at phase 4. TAZ increased by 1.25 mg/d (P = 0.045) in the C group and by 0.81 mg/d (P = 0.058) in the LP group at phase 2. At phase 3, the increases were 2.66 mg/d (P = 0.002) in the C group and 2.28 mg/d (P = 0.0004) in the LP group, compared with a 1.37-mg/d increase in PR. Measured TAZ was greater than predicted values in phases 2-4.Conclusions: Upregulation of zinc absorption in late pregnancy and early lactation matches increases in PRs of pregnant and lactating women, regardless of dietary phytate, which has implications for dietary zinc requirements of pregnant and lactating women.


Subject(s)
Diet , Gestational Age , Intestinal Absorption , Lactation , Nutritional Requirements , Phytic Acid/administration & dosage , Zinc/metabolism , Adult , Biological Availability , Double-Blind Method , Female , Guatemala , Humans , Indians, Central American , Lactation/physiology , Longitudinal Studies , Nutritional Status , Phytic Acid/adverse effects , Pregnancy , Pregnancy Complications , Pregnancy Trimester, Third , Prospective Studies , Up-Regulation , Zea mays/chemistry , Zinc/deficiency
2.
BMC Pediatr ; 11: 4, 2011 Jan 13.
Article in English | MEDLINE | ID: mdl-21232139

ABSTRACT

BACKGROUND: Inadequate and inappropriate complementary feeding are major factors contributing to excess morbidity and mortality in young children in low resource settings. Animal source foods in particular are cited as essential to achieve micronutrient requirements. The efficacy of the recommendation for regular meat consumption, however, has not been systematically evaluated. METHODS/DESIGN: A cluster randomized efficacy trial was designed to test the hypothesis that 12 months of daily intake of beef added as a complementary food would result in greater linear growth velocity than a micronutrient fortified equi-caloric rice-soy cereal supplement. The study is being conducted in 4 sites of the Global Network for Women's and Children's Health Research located in Guatemala, Pakistan, Democratic Republic of the Congo (DRC) and Zambia in communities with toddler stunting rates of at least 20%. Five clusters per country were randomized to each of the food arms, with 30 infants in each cluster. The daily meat or cereal supplement was delivered to the home by community coordinators, starting when the infants were 6 months of age and continuing through 18 months. All participating mothers received nutrition education messages to enhance complementary feeding practices delivered by study coordinators and through posters at the local health center. Outcome measures, obtained at 6, 9, 12, and 18 months by a separate assessment team, included anthropometry; dietary variety and diversity scores; biomarkers of iron, zinc and Vitamin B12 status (18 months); neurocognitive development (12 and 18 months); and incidence of infectious morbidity throughout the trial. The trial was supervised by a trial steering committee, and an independent data monitoring committee provided oversight for the safety and conduct of the trial. DISCUSSION: Findings from this trial will test the efficacy of daily intake of meat commencing at age 6 months and, if beneficial, will provide a strong rationale for global efforts to enhance local supplies of meat as a complementary food for young children. TRIAL REGISTRATION: NCT01084109.


Subject(s)
Dietary Supplements , Food, Fortified , Infant Nutritional Physiological Phenomena , Adult , Anthropometry , Child Development , Communicable Diseases/epidemiology , Democratic Republic of the Congo/epidemiology , Edible Grain , Female , Growth Disorders/epidemiology , Growth Disorders/etiology , Growth Disorders/prevention & control , Guatemala/epidemiology , Health Education , Humans , Infant , Malnutrition/complications , Malnutrition/epidemiology , Malnutrition/prevention & control , Meat , Mothers/psychology , Pakistan/epidemiology , Pilot Projects , Zambia/epidemiology
3.
J Midwifery Womens Health ; 54(2): 133-141.e1, 2009.
Article in English | MEDLINE | ID: mdl-19249659

ABSTRACT

The objective of this study was to compare a Tibetan traditional medicine (the uterotonic Zhi Byed 11 [ZB11]) to oral misoprostol for prophylaxis of postpartum hemorrhage (PPH). We conducted a double-blind randomized controlled trial at three hospitals in Lhasa, Tibet, People's Republic of China. Women (N = 967) were randomized to either ZB11 or misoprostol groups. Postpartum blood loss was measured in a calibrated blood collection drape. The primary combined outcome was incidence of PPH, defined as measured blood loss (MBL) > or = 500 mL, administration of open label uterotonics, or maternal death. We found that the rate of the combined outcome was lower among the misoprostol group (16.1% versus 21.8% for ZB11; P = .02). Frequency of PPH was lower with misoprostol (12.4% versus 17.4%; P = .02). There were no significant differences in MBL > 1000 mL or mean or median MBL. Fever was significantly more common in the misoprostol group (P = .03). The rate of combined outcome was significantly lower among women receiving misoprostol. However, other indices of obstetric hemorrhage were not significantly different.


Subject(s)
Medicine, Tibetan Traditional , Misoprostol/therapeutic use , Oxytocics/therapeutic use , Plant Preparations/therapeutic use , Postpartum Hemorrhage/prevention & control , Adult , Animals , Carbonates , Double-Blind Method , Female , Humans , Misoprostol/adverse effects , Oxytocics/adverse effects , Phytotherapy , Plants, Medicinal , Pregnancy , Snakes , Sulfur , Tibet , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL